We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
iHeartMedia
IHRT
$274M
| $0 | ﹤0.01% |
5
-466
| -99% | -$9.29K |
2021 Q4
1 quarter
|
|
3102
i3 Verticals
IIIV
$299M
| $0 | ﹤0.01% |
7
-205
| -97% | -$5.05K |
2021 Q4
1 quarter
|
|
|
IMCC
3103
IM Cannabis
IMCC
$803K
| – | – |
0
| – | – |
2022 Q1
0 quarters
|
|
3104
Immunic
IMUX
$96.9M
| – | – |
0
| – | – |
2018 Q2
15 quarters
|
|
3105
Immunovant
IMVT
$5.68B
| – | – |
-382
| Closed | -$3K | – |
|
3106
indie Semiconductor
INDI
$464M
| – | – |
-20
| Closed | – | – |
|
3107
InMode
INMD
$824M
| – | – |
-206
| Closed | -$9.23K | – |
|
3108
Insmed
INSM
$21.7B
| – | – |
-119
| Closed | -$3K | – |
|
3109
Innoviva
INVA
$1.51B
| – | – |
-189
| Closed | -$3K | – |
|
3110
Interparfums
IPAR
$3.69B
| – | – |
-6
| Closed | -$1K | – |
|
3111
DELISTED
iRobot
IRBT
| – | – |
-2
| Closed | – | – |
|
3112
iRadimed
IRMD
$1.14B
| $0 | ﹤0.01% |
2
-55
| -96% | -$2.54K |
2021 Q4
1 quarter
|
|
3113
Integer Holdings
ITGR
$4.31B
| $0 | ﹤0.01% |
2
| – | – |
2021 Q4
1 quarter
|
|
3114
Invesco Mortgage Capital
IVR
$615M
| $0 | ﹤0.01% |
21
| – | – |
2021 Q2
3 quarters
|
|
3115
Invivyd
IVVD
$197M
| – | – |
-10
| Closed | – | – |
|
3116
The Joint Corp
JYNT
$97.7M
| – | – |
-21
| Closed | -$1K | – |
|
3117
KALA BIO
KALA
$3.72M
| – | – |
0
| – | – |
2021 Q1
4 quarters
|
|
3118
Kaiser Aluminum
KALU
$2.43B
| $0 | ﹤0.01% |
1
| – | – |
2021 Q4
1 quarter
|
|
3119
Kimball Electronics
KE
$636M
| $0 | ﹤0.01% |
13
-246
| -95% | -$4.77K |
2021 Q3
2 quarters
|
|
3120
Kiniksa Pharmaceuticals
KNSA
$6.24B
| – | – |
-24
| Closed | – | – |
|
3121
Kosmos Energy
KOS
$1.6B
| $0 | ﹤0.01% |
68
| – | – |
2021 Q4
1 quarter
|
|
3122
Karyopharm Therapeutics
KPTI
$7.96M
| – | – |
-22
| Closed | -$2K | – |
|
3123
KraneShares Global Carbon Strategy ETF
KRBN
$137M
| – | – |
-50
| Closed | -$3K | – |
|
3124
KRONOS Worldwide
KRO
$852M
| $0 | ﹤0.01% |
15
-296
| -95% | -$4.4K |
2021 Q3
2 quarters
|
|
3125
KVH Industries
KVHI
$109M
| $0 | ﹤0.01% |
29
| – | – |
2020 Q3
6 quarters
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.